Manulife US REIT

SINGAPORE (Aug 13): The manager of Manulife US Real Estate Investment Trust (Manulife US REIT) has declared a DPU of 1.53 US cents, up 17.7% from 1.30 cents declared for the same quarter last year. 

SINGAPORE (June 19): Manulife US REIT (MUST) currently has a portfolio of eight trophy and class A office properties located in Los Angeles, New York, Washington DC and Atlanta, with a total net lettable area (NLA) of 4.16 million sf and valued at US$1.86

SINGAPORE (April 29): Manulife US REIT has agreed to acquire a freehold 11-storey Class ‘A’ office asset at the Washington Metropolitan area in Fairfax, Virginia, for a consideration of US$122 million ($166.1 million) from Carr Properties.

SINGAPORE (Feb 12): RHB Research is maintaining its “buy” call on Manulife US REIT with a higher target price of 94 US cents compared to 92 US cents previously, upon lowering COE assumptions to 8.3% from 8.4% in its dividend discount model (DDM) to r

SINGAPORE (Oct 16): RHB is reiterating its “overweight” rating on Singapore REITs (SREITs), as it believes that selective SREITs still offer value for investors, despite lingering concerns over rising interest rates.

SINGAPORE (Apr 16): RHB is maintaining its “buy” on Manulife US REIT but raising its target to US$1 from 98 US cents to factor in 1-2% higher FY18-20 DPU forecasts on contributions from its latest acquisitions.

SINGAPORE (Apr 13): Manulife US REIT is acquiring two office properties – namely 1750 Pennsylvania Avenue (Penn) in Washington DC and Phipps Tower (Phipps) in Buckhead, Atlanta – from its sponsor’s indirectly wholly-owned subsidiary, John Hancock L

SINGAPORE (Feb 20): RHB Research is upbeat on Singapore’s growth outlook and expects a positive “post-Budget” market reaction with a preference for exposure to the consumer, real estate, REITs and banking sectors.